IL6 and ovarian carcinoma: To assess the migratory capability of ovarian cancer cells in an inflammatory and glucose deprived microenvironment, OVCAR3 and OAW42 cells were treated with 50 ng/mL IL-6, 100 μM resveratrol (RV) or both in the presence or absence of glucose (Figure 1).